HomeAuthorsPosts by Sam Atkinson

Sam Atkinson

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge in profit for the third quarter ended May 31, 2026. This performance marks a decisive shift from a period of recovery toward a new phase of resilient growth in the...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the country grapples with a growing burden of non-communicable diseases (NCDs), particularly diabetes and chronic kidney disease. Recent estimates show that one-in-six Malaysians has diabetes, while one-in-seven is at risk of chronic...
spot_img

Keep exploring

SGX-LISTED COMPANIES

Solving The Hour Glass 1H 2026 Profit Mystery

We Read a Luxury Watch Retailer's Financial Report So You Don't Have To. Here...
SGX-LISTED COMPANIES

Massive Construction Demand Boosts KSH 1H FY2026

From Red to Black: 5 Key Insights from KSH's Impressive Turnaround Introduction: Witnessing a company reverse...
SGX-LISTED COMPANIES

Why Livingstone Health’s Revenue Is Up But Profits Are Down In HY2026

4 Surprising Truths Hidden in Livingstone Health's Latest Financial Report Introduction: This article unpacks the latest...
SGX-LISTED COMPANIES

95% Revenue Drop: Disaster Q1 2026 For Incredible Holdings

5 Shocking Truths We Uncovered in Incredible Holdings Latest Financial Report Introduction: In the latest quarterly...
SGX-LISTED COMPANIES

CSC Holdings Reports Huge 1H FY26 Revenue Growth, But Profits Halved

Revenue Soared, but Profits Were Halved: 3 Surprising Insights Hidden in CSC Holdings 1H...
SGX-LISTED COMPANIES

Old Chang Kee 1H 2026 Profit Gets Crushed

Flat Sales, Falling Profits: 5 Key Insights from Old Chang Kee's Latest Financials For anyone...
SGX-LISTED COMPANIES

How Each Of Yoma Strategic’s Core Segments Drove Its 1H2026 Performance

4 Surprising Stories from Yoma Strategic's Latest Earnings Introduction: This post aims to distill the most...
SGX-LISTED COMPANIES

9R Limited 1H 2026 Profit Vanishes

Sales Grew 12%, So Why Did 9R's Profits Disappear? 4 Surprising Insights From Their...
SGX-LISTED COMPANIES

Meta Health Admits Going Concern Risk After Q3 2025

We Read Meta Health's Q3 2025 Financial Report. Here Are 4 Surprising Takeaways In business,...
SGX-LISTED COMPANIES

Addvalue Technologies Jumps 3,700% In 1H 2025/26

From $52K to $1.98M: The Story Behind This Tech Firm's Astronomical 3,702% Profit Surge In...
SGX-LISTED COMPANIES

What’s Changing at SingPost? A Look Inside Their 1H FY25/26

5 Surprising Truths Buried in SingPost's Latest Financial Report When Singapore Post (SingPost) announced its...
SGX-LISTED COMPANIES

The Truth About Boustead Singapore’s 1H FY2026 Profit Drop They Didn’t Show

Boustead’s Flat Results Hide a 27% Profit Drop: 4 Surprising Takeaways From Its Latest...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...